Enfuvirtide is a HIV fusion inhibitor peptide. It is filed in this library under immune & defense, a navigation topic rather than a statement of where it acts. As a regulatory matter it was approved by the FDA but is no longer marketed in the United States.
Regulatory status
Enfuvirtide was approved by the FDA, but the product is no longer marketed in the United States.
An approval that has been discontinued is not the same as a drug you can obtain today.
The evidence
One source on Enfuvirtide, resolved to its journal of record. The title is listed so you can judge the evidence rather than take a summary on trust.
Nearby
Before any compound, the useful question is what your bloodwork already says. The OPTML Score reads a full panel against optimal ranges.
See the OPTML ScoreEducational reference only. This page explains what has been published about Enfuvirtide. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.
Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
All 150 peptides